معرفی
Dr. Gerard T. Berry is the Harvey Levy Chair in Metabolism at Boston Children's Hospital and a Professor of Pediatrics at Harvard Medical School. He serves as Director of the Harvard Medical School Biochemical Genetics Training Program and is actively involved in clinical and basic research on inborn metabolic disorders, particularly galactosemia and inositol metabolism.
Dr. Berry earned his MD from Jefferson Medical College, completed pediatric residency at Thomas Jefferson University Hospital, and pursued fellowship training in biochemical genetics and pediatric endocrinology at the Children's Hospital of Philadelphia. He joined the University of Pennsylvania faculty in 1981 and later moved to Harvard Medical School, where he has held leadership and academic roles.
His research focuses on carbohydrate metabolism, especially galactosemia, and inositol metabolism in the developing brain. He employs advanced techniques including in vivo isotope kinetic studies, mass spectrometry, LC-MS/MS enzyme assays, and CRISPR/Cas9 gene editing in iPSC-derived neuronal models. His work explores genotype-phenotype correlations, brain myo-inositol deficiency, and the development of novel therapies for rare metabolic diseases.
Analysis of his recent publications reveals a sustained focus on galactosemia, congenital disorders of glycosylation (CDG), urea cycle disorders, and long-chain fatty acid oxidation disorders. His research spans from basic mechanisms to clinical trials and natural history studies, often in international collaboration through networks such as GalNet and the UDN Metabolomics Working Group.
- Emmanuel Shapiro Award, Society for Inherited Metabolic Diseases (SIMD), 2004
Dr. Berry has made significant contributions to clinical guidelines and has advised on the management of metabolic diseases. He has been instrumental in establishing international patient registries and advancing the understanding of long-term outcomes in rare metabolic conditions. While no specific grants are listed in the text, his extensive publication record in major journals indicates sustained research funding and leadership. He collaborates widely with researchers in the USA and Europe.
His laboratory investigates mechanisms of neuronal dysfunction in galactosemia using iPSC-derived neurons and studies brain myo-inositol deficiency using SLC5A3 knockout mouse models. These models help elucidate the pathophysiology of CNS complications in metabolic diseases and test potential therapeutic interventions.
